tallózása szerző szerint "Pipis, Judit"

A találatok rendezése: Rendezés: Találatok:

  • Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats 
    Sárközy, Márta; Zvara, Ágnes; Gyemant N; Fekete V; Kocsis-Fodor, Gabriella; Pipis, Judit; Szűcs, Gergő; Csonka, Csaba; Puskás, László; Ferdinandy, Péter; Csont, Tamás Bálint (2013)
    ABSTRACT: BACKGROUND: Metabolic syndrome (coexisting visceral obesity, dyslipidemia, hyperglycemia, and hypertension) is a prominent risk factor for cardiovascular morbidity and mortality, however, its effect on cardiac ...
  • Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective 
    Bencsik, Péter; Pálóczi, János; Kocsis-Fodor, Gabriella; Pipis, Judit; Belecz, István; Varga, Zoltán; Csonka, Csaba; Görbe, Anikó; Csont, Tamás Bálint; Ferdinandy, Péter (2014)
    Pharmacological inhibition of matrix metalloproteinase-2 (MMP-2) is a promising target for acute cardioprotection against ischemia/reperfusion injury. Therefore, here we investigated if the MMP inhibitor ilomastat administered ...
  • Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats 
    Kiss, Krisztina; Csonka, Csaba; Pálóczi, János; Pipis, Judit; Görbe, Anikó; Kocsis-Fodor, Gabriella; Murlasits Z; Sárközy, Márta; Szűcs, Gergő; Holmes CP; Pan Y; Bhandari A; Csont, Tamás Bálint; Shamloo M; Woodburn KW; Ferdinandy, Péter; Bencsik, Péter (2016)
    Erythropoietin (EPO) has been shown to protect the heart against acute myocardial infarction in pre-clinical studies, however, EPO failed to reduce infarct size in clinical trials and showed significant safety problems. ...
  • Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats 
    Sárközy, Márta; Szűcs, Gergő; Fekete V; Pipicz, Márton; Eder K; Gáspár, Renáta; Sója, Andrea; Pipis, Judit; Ferdinandy, Péter; Csonka, Csaba; Csont, Tamás Bálint (2016)
    BACKGROUND: There is a spectacular rise in the global prevalence of type 2 diabetes mellitus (T2DM) due to the worldwide obesity epidemic. However, a significant proportion of T2DM patients are non-obese and they also have ...